article thumbnail

Human-centred innovation in a digital world.

Paul Hobcraft

Already most of the major pharmaceutical or biotechnology companies had some levels of vaccine platform technologies. Just announced is the collaborative work that Siemens has been doing with BioNTech, getting involved in converting existing facilities in Germany to produce the mRNA-vaccine project. Opinions are my own.

Software 278
article thumbnail

Deep Tech Innovation Needs Deep Networks

100%Open

It may be the same effect that causes buses to arrive in multiples of three, but at 100%Open, we’ve noticed an upsurge in the quantity of deep tech projects. Fields such as AI, advanced materials, blockchain, digital twins, biotechnology, robotics, drones, photonics, and quantum computing all of a sudden appear to be gaining traction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Power of Innovation: Key Topics and Content from Dynamic Keynote Speakers

Leapfrogging

A dynamic speaker can transform the atmosphere, creating an engaging and thought-provoking experience for all attendees. Offering continuous learning opportunities to keep team members sharp and engaged. Empowerment : Empower leaders to make decisions and take ownership of innovation projects.

article thumbnail

Human-centred innovation in a digital world.

Paul Hobcraft

Already most of the major pharmaceutical or biotechnology companies had some levels of vaccine platform technologies. Just announced is the collaborative work that Siemens has been doing with BioNTech, converting existing facilities in Germany to produce the mRNA-vaccine project. Register through this link for on-demand viewing: sie.ag/3tnhVD4.

Software 130
article thumbnail

Human-centred innovation in a digital world.

Paul Hobcraft

Already most of the major pharmaceutical or biotechnology companies had some levels of vaccine platform technologies. Just announced is the collaborative work that Siemens has been doing with BioNTech, converting existing facilities in Germany to produce the mRNA-vaccine project. Register through this link for on-demand viewing: sie.ag/3tnhVD4.

Software 130
article thumbnail

A follow-up trip to Europe

Yet2

Recent successful projects include scouting for high temperature coatings, a tour of west coast biotechnologies, ongoing strategic scouting for digestive health ingredients, ongoing patent portfolio monitoring in healthcare, and sourcing of partners performing simulation services for manufacturing. We have cross-industry expertise.

Meeting 40